Group 1 - The core viewpoint is that the humanoid robot sector is expected to experience explosive growth in 2024, particularly in logistics scenarios transitioning from demo to customer trials in the second half of this year [1] - The overseas market is anticipated to be the first choice for logistics applications due to higher labor costs [1] - Companies with strong secondary development capabilities and leading core suppliers in commercialization progress are recommended for attention [1] Group 2 - The airport sector is highlighted as a key area for bottom-fishing opportunities, with international passenger flow recovery being a major focus [2] - A series of policies driving macroeconomic recovery and domestic consumption is expected to enhance the commercial segment's average transaction value by 2025 [2] - The revision of duty-free agreements and the progress of tax shop leasing require further monitoring, with limited downside potential for duty-free discount rates [2] Group 3 - The blood products industry is projected to maintain steady growth, with stable issuance of albumin and immunoglobulin products in the first half of 2025 [3] - The increase in domestic albumin issuance and rapid growth in factor products reflect ongoing expansion in product pipelines [3] - Companies positioned at the industry forefront, focusing on both organic growth and external integration to expand plasma station resources, are recommended for attention [3]
泛人形机器人明年有望迎来爆发增长